Physician profile
Joseph J Jankiewicz
NPI 1124030010
$2,601,289.92
in general payments reported to CMS, 2019-2025
10 companies · $621K in 2025
The $621K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319K · 2020: $281K · 2021: $385K · 2022: $440K · 2023: $555K · 2024: $249 · 2025: $621K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Consulting Fee: $17K · Food and Beverage: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,158,402.50 |
| Consulting Fee | $16,750.00 |
| Food and Beverage | $1,068.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $2,590,653.07 | 2019-2025 | Djo Surgical |
| Think Surgical, INC. | $8,842.78 | 2019 | |
| Djo, LLC | $750.00 | 2019 | |
| Stryker Corporation | $491.15 | 2019-2024 | Mako, Triathlon |
| Lima USA, INC. | $248.10 | 2019-2020 | |
| Davol INC. | $138.75 | 2022 | |
| Becton, Dickinson and Company | $53.50 | 2023 | |
| Smith+Nephew, INC. | $49.38 | 2021 | |
| Heraeus Medical, LLC. | $42.56 | 2021 | |
| Convatec INC. | $20.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Jankiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.